Article

Comparing multifocal, accommodating IOLs

Author(s):

Outcomes for three presbyopia-correcting IOLs-one accommodating and two multifocals-were similar, said Robert Edward Ang, MD.

New Orleans-Outcomes for three presbyopia-correcting IOLs-one accommodating and two multifocals-were similar, said Robert Edward Ang, MD.

“In terms of binocular high-contrast, uncorrected distance visual acuity, there was no statistical difference in distance vision among the three lenses,” said Dr. Ang, of Makati, Philippines.

Refractive outcomes were also stable in all lenses, as long as the capsule was taken care of, he added. 

At 1 year, his prospective, randomized study compared 71 patients with a mean age of 65 years implanted bilaterally either with an accommodating IOL (Crystalens, Bausch + Lomb) or one of two multifocal IOLs (ReSTOR, Alcon Laboratories; or Tecnis Multifocal, Abbott Medical Optics).

For uncorrected intermediate visual acuity, his study showed the Crystalens outcomes were superior. For uncorrected near visual acuity, his study recorded better results with the multifocals, especially the ReSTOR.

In terms of distance-corrected intermediate visual acuity, patients in the study had the best outcomes with Crystalens. With distance-corrected near visual acuity, the multifocals showed better outcomes. 

Dr. Ang also tracked reports of halos and starbursting, both of which were less with Crystalens, but YAG rates were higher with this IOL. The lowest YAG rates were with the Tecnis.

Results for binocular mean visual acuities in the 3 groups: Crystalens, ReSTOR, and Tecnis, respectively.

  • Uncorrected distance visual acuity:                     20/20, 20/20, 20/21

  • Uncorrected intermediate visual acuity:               20/20, 20/24, 20/26

  • Uncorrected near visual acuity visual acuity:       20/25, 20/20, 20/23

  • Distance-corrected intermediate visual acuity:     20/20, 20/24, 20/25

  • Distance-corrected near visual acuity:                 20/26, 20/19, 20/21

For more articles in this issue of Ophthalmology Times Conference Brief click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.